Login / Signup

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.

Diego Martinez-UrbistondoAna HuertaDavid Navarro-GonzálezLaura Sánchez-IñigoAlejandro Fernandez-MonteroManuel F LandechoJosé Alfredo Martínez HernándezJuan C Pastrana-Delgado
Published in: European journal of clinical investigation (2023)
MAFLD interplay with MetS and PreDM might help to discriminate patient risk of T2DM in the clinical setting through metabolic remodelling-based phenotypes.
Keyphrases
  • glycemic control
  • metabolic syndrome
  • insulin resistance
  • blood glucose
  • type diabetes
  • adipose tissue
  • weight loss